Healthcare / Medical Care FacilitiesKuala Lumpur
$0.25
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $50.2M · quality 81.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
42/100
C
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.2B
P/E
25.0x
↑EV/EBITDA
14.5x
↑ROE
29.0%
↑Gross Margin
60.6%
↑Debt/Equity
0.12
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+24.7%
FCF CAGR
+11.9%
FCF margin
26.9%
FCF / Net income
0.83x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $176.8M · net income $57.5M · FCF $47.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $176.8M | $176.8M | $167.6M | $137.5M | $91.1M |
| Net Income | $57.5M | $57.5M | $52.9M | $53.2M | $14.3M |
| EBITDA | $83.0M | $83.0M | $79.1M | $75.2M | $39.3M |
| EPS | — | — | 0.01 | 0.01 | 0.00 |
| Gross Margin | 60.6% | 60.6% | 58.1% | 55.7% | 51.1% |
| Operating Margin | 41.9% | 41.9% | 43.5% | 40.5% | 34.3% |
| Net Margin | 32.5% | 32.5% | 31.6% | 38.7% | 15.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.12 | 0.12 | 0.09 | 0.45 | 0.75 |
| Current Ratio | 3.22 | 3.22 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $47.6M | $47.6M | $50.2M | $59.7M | $33.9M |
| Returns | |||||
| ROE | 29.0% | 29.0% | 28.2% | 103.2% | 35.4% |
| Valuation | |||||
| P/E | 25.00 | 25.00 | 27.39 | — | — |
| EV/EBITDA | 14.50 | 14.50 | 19.26 | — | — |
| P/B | 6.14 | 6.14 | 8.17 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 5.5% | 5.5% | 21.9% | 50.9% | — |
| EPS Growth | — | — | 5.0% | 272.1% | — |
| Dividend Yield | 4.0% | 4.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-6.7%
Start / end P/E
n/dx → n/dx
EPS bridge
0.01 → n/d
Residual
-10.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.